Stanford Comprehensive Epilepsy Program
Overview: Stanford is a highest-level epilepsy center, offering new methods of treating and diagnosing epilepsy. The mission is to deliver the best available care and beyond, while pushing the forefronts of epilepsy care beyond the ordinary.
The core of the program is a large outpatient epilepsy outpatient clinic with approximately 1200 visits in 2019. The beautiful Stanford new hospital opened in 2020, including a 10-bed dedicated epilepsy monitoring unit (EMU). In 2019, 242 patients were admitted to the unit, when the EMU was five beds in the old hospital. Once past the COVID-19 pandemic, admissions are expected to increase. Average length of stay was 4 days. A total of 817 off-service long-term video-EEGs (mostly for the ICU and Neurology service) and 125 routine outpatient EEGs.
Dr. Parvizi leads the neurological side of the epilepsy surgery and refractory epilepsy program. Stanford is a Level IV (highest level) program in the ratings of the National Association of Epilepsy Centers. In 2019, Stanford performed 88 epilepsy surgeries, counting implants, but not battery changes. These comprised 27 RNS implants, 13 DBS implants, 8 new VNS implants, 17 resections and 21 invasive monitoring studies.
Strategic Goal: To serve as a global referral center for refractory epilepsy that does not respond to anti-seizure medications.
- Advanced surgery techniques
- Diagnosis and treatment of non-epileptic seizures
Adult Epilepsy Patient Care
Stanford Health Care’s nationally-recognized Comprehensive Epilepsy Program provides comprehensive care and treatment for epilepsy.
Pediatric Epilepsy Patient Care
The Pediatric Epilepsy Center at Lucile Packard Children’s Hospital Stanford